Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03044431 · ClinicalTrials.gov registry record
Autologous Stem Cell Treatment for Chronic Lung Disease Study
A clinical trial of COPD and Interstitial Lung Disease, sponsored by Lung Institute.
- Completed
- Registry status
- 207
- Enrollment target
- 1
- Study location
NCT03044431 is a study of COPD and Interstitial Lung Disease that has completed, run by Lung Institute. The registered enrollment target is 207 participants, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03044431, a study of COPD and Interstitial Lung Disease, has completed, sponsored by Lung Institute.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Lung Institute is to collect and isolate a patient's own cells and platelet rich plasma (PRP) and deliver the product back to the patient the same day. Lung Institute's treatment is limited to self-funded patients with chronic lung disease- chronic obstructive pulmonary disease (COPD) and restrictive lung diseases such as pulmonary fibrosis (PF) and interstitial lung disease (ILD). The patient's cells and platelet rich plasma are harvested through venous or bone marrow collection techniques. The hypothesized outcomes of therapy are safety and minimization of adverse events, a perceived improvement in the patient's lung condition (to be determined by their perceived quality of life), an improvement in the FEV1 among COPD patients, the ability to reduce supplemental oxygen use, the ability to function well without the use of rescue inhalers, reduction of secondary pulmonary infections, reduction in emergency room visits and exacerbations related to their disease.
Conditions Studied
Interventions
- PROCEDURE Cell therapy
Study Locations (1)
Texas
- Lung Institute Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2017-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03044431
The ClinicalTrials.gov registry entry for NCT03044431 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (91% lower). The listed sponsor is Lung Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Cell therapy is the first listed.
NCT03044431 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03044431 about?
NCT03044431 is a clinical study titled "Autologous Stem Cell Treatment for Chronic Lung Disease Study". The purpose of the Lung Institute is to collect and isolate a patient's own cells and platelet rich plasma (PRP) and deliver the product back to the patient the same day. Lung Institute's treatment is limited to self-funded patients with chronic lung disease- chronic obstructive pulmonary disease (C...
What is the current status of trial NCT03044431?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2016-04-01. Estimated completion is 2017-06-09.
What conditions does trial NCT03044431 study?
This clinical trial studies the following conditions: COPD, Interstitial Lung Disease.
What interventions are being tested in trial NCT03044431?
The interventions under investigation include: Cell therapy (PROCEDURE).
Who is sponsoring clinical trial NCT03044431?
This trial is sponsored by Lung Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03044431 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.